BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1976060)

  • 1. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat.
    Murata R; Haughey DB; Jusko WJ
    Drug Metab Dispos; 1990; 18(4):403-8. PubMed ID: 1976060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.
    Huang ML; Jusko WJ
    J Pharmacokinet Biopharm; 1990 Oct; 18(5):401-21. PubMed ID: 2266496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone pharmacokinetics. III. Influence of thyroid dysfunction on amiodarone absorption and disposition.
    Weir SJ; Ueda CT
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1026-32. PubMed ID: 3418508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of prednisolone in the rabbit.
    Khalafallah N; Jusko WJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):719-25. PubMed ID: 6726655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice.
    Wyska E; Pekala E; Szymura-Oleksiak J
    Chirality; 2006 Aug; 18(8):644-51. PubMed ID: 16721727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
    Frey FJ; Horber FF; Frey BM
    Clin Pharmacol Ther; 1988 Nov; 44(5):510-21. PubMed ID: 2972434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG; DiSanto AR; Gillespie WR; Albert KS
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone metabolism and excretion in the isolated perfused rat kidney.
    Rocci ML; Szefler SJ; Acara M; Jusko WJ
    Drug Metab Dispos; 1981; 9(3):177-82. PubMed ID: 6113924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of different thyroid status on the pharmacokinetics of diazepam].
    Xu F; Zhang Y; Lou Y
    Yao Xue Xue Bao; 1998 Aug; 33(8):571-5. PubMed ID: 12016895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone and prednisone exhibit linear extraction in the perfused rabbit liver.
    Hale VG; Benet LZ
    Drug Metab Dispos; 1991; 19(1):87-93. PubMed ID: 1673428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hypothyroidism on nerve growth factor and norepinephrine concentrations in weight-bearing and non-weight-bearing bones of rats.
    Yao M; Dooley PC; Schuijers JA; Grills BL
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):319-24. PubMed ID: 15615500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
    Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma homocysteine levels of rats with experimentally induced hypothyroidism and hyperthyroidism.
    Ozkan Y; Dönder E; Güney H; Baydaş G
    Neuro Endocrinol Lett; 2005 Oct; 26(5):536-40. PubMed ID: 16264404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and oxytocin release and the thyroid function.
    Ciosek J; Drobnik J
    J Physiol Pharmacol; 2004 Jun; 55(2):423-41. PubMed ID: 15213363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of prednisone and prednisolone in a case of hypothyroidism: effect of replacement therapy.
    Bergamaschi S; Rusconi R; Gervasoni M; Rigamonti AE; Cella S; Bareggi SR
    Steroids; 2005 Oct; 70(11):787-9. PubMed ID: 16045952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of experimental hypo- and hyperthyroidism on serum adiponectin.
    Aragão CN; Souza LL; Cabanelas A; Oliveira KJ; Pazos-Moura CC
    Metabolism; 2007 Jan; 56(1):6-11. PubMed ID: 17161219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine kinase activity in homogenates of rat thyroid lobes from euthyroid, hypothyroid and/or hyperthyroid rats incubated with EGF: studies ex vivo in vitro.
    Karbownik M; Modrzejewska H; Gesing A; Greger J; Lewinski A
    Endocr Regul; 1999 Mar; 33(1):17-23. PubMed ID: 10200584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.